"If the deal breaks up ... the stock [still] heads through $110," Cramer said in an exclusive conference call with members of his Action Alerts PLUS club for investors. "I think you win either way."
More from Video
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.